Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
3.
Nat Commun ; 13(1): 7755, 2022 12 15.
Article in English | MEDLINE | ID: mdl-36517468

ABSTRACT

Synthetic biology often involves engineering microbial strains to express high-value proteins. Thanks to progress in rapid DNA synthesis and sequencing, deep learning has emerged as a promising approach to build sequence-to-expression models for strain optimization. But such models need large and costly training data that create steep entry barriers for many laboratories. Here we study the relation between accuracy and data efficiency in an atlas of machine learning models trained on datasets of varied size and sequence diversity. We show that deep learning can achieve good prediction accuracy with much smaller datasets than previously thought. We demonstrate that controlled sequence diversity leads to substantial gains in data efficiency and employed Explainable AI to show that convolutional neural networks can finely discriminate between input DNA sequences. Our results provide guidelines for designing genotype-phenotype screens that balance cost and quality of training data, thus helping promote the wider adoption of deep learning in the biotechnology sector.


Subject(s)
Deep Learning , Neural Networks, Computer , Machine Learning , Proteins
4.
Asian Pac J Cancer Prev ; 19(12): 3427-3434, 2018 Dec 25.
Article in English | MEDLINE | ID: mdl-30583665

ABSTRACT

Background: Bronchogenic carcinoma (lung cancer) is one of the leading causes of death. Although many compounds isolated from natural products have been used to treat it, drug resistance is a serious problem, and alternative anti-cancer drugs are required. Here, melittin from Apis mellifera venom was used, and its effects on bronchogenic carcinoma cell proliferation and tumour-associated macrophage differentiation were evaluated. Methods: The half maximal inhibitory concentration (IC50) of melittin was measured by MTT. Cell death was observed by annexin V and propidium iodide (PI) co-staining followed by flow cytometry. Cell cycle arrest was revealed by PI staining and flow cytometry. To investigate the tumour microenvironment, differentiation of circulating monocytes (THP-1) into tumour-associated macrophages (TAMs) was assayed by sandwich-ELISA and interleukin (IL)-10 levels were determined. Cell proliferation and migration was observed by flat plate colony formation. Secretion of vascular endothelial growth factor (VEGF) was detected by ELISA. The change in expression levels of CatS, Bcl-2, and MADD was measured by quantitative RT-PCR. Results: Melittin was significantly more cytotoxic (p < 0.01) to human bronchogenic carcinoma cells (ChaGo-K1) than to the control human lung fibroblasts (Wi-38) cells. At 2.5 µM, melittin caused ChaGo-K1 cells to undergo apoptosis and cell cycle arrest at the G1 phase. The IL-10 levels showed that melittin significantly inhibited the differentiation of THP-1 cells into TAMs (p < 0.05) and reduced the number of colonies formed in the treated ChaGo-K1 cells compared to the untreated cells. However, melittin did not affect angiogenesis in ChaGo-K1 cells. Unlike MADD, Bcl-2 was up-regulated significantly (p < 0.05) in melittin-treated ChaGo-K1 cells. Conclusion: Melittin can be used as an alternative agent for lung cancer treatment because of its cytotoxicity against ChaGo-K1 cells and the inhibition of differentiation of THP-1 cells into TAMs.


Subject(s)
Apoptosis/drug effects , Carcinoma, Bronchogenic/drug therapy , Cell Cycle Checkpoints/drug effects , Cell Differentiation/drug effects , G1 Phase/drug effects , Macrophages/drug effects , Melitten/pharmacology , THP-1 Cells/drug effects , Carcinoma, Bronchogenic/metabolism , Carrier Proteins/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Death Domain Receptor Signaling Adaptor Proteins/metabolism , Humans , Interleukin-10/metabolism , Macrophages/metabolism , Monocytes/drug effects , Monocytes/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , THP-1 Cells/metabolism , Vascular Endothelial Growth Factor A/metabolism
5.
Biotechniques ; 65(3): 113-119, 2018 09.
Article in English | MEDLINE | ID: mdl-30227739

ABSTRACT

[Formula: see text] Synthetic biology has enormous potential to solve problems in health, agriculture, and energy. Bill Jia and Arin Wongprommoon explore engineering approaches to controlling biological processes.


Subject(s)
Synthetic Biology/methods , Genetic Engineering , Signal Transduction , Synthetic Biology/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...